Back to search

University of Crete (UOC)

Μελέτη επαγωγής ακτινοευαισθησίας νέων παραγώγων κιναζολινών με αντικαρκινική δράση σε καρκινικές κυτταρικές σειρές που υπερεκφράζουν υποδοχείς ErbB.

Abstract

dc:description

Nowadays, quinazoline drugs, inhibiting EGFR phosphorylation, are often used as targeted anti-cancer therapy. EGFR is a protein that is often overexpressed or mutated in patients’ tumors exhibiting radioresistance. However, the occurrence of adverse effects and the acquired resistance of patients to chemotherapy and radiotherapy demands the development of new compounds with anticancer and radiosensitising activity, for personalised therapy. In the framework of this thesis, 13 novel quinazoline derivatives were studied in vitro, using the human radioresistant cancer cell line A431 overexpressing EGFR. These compounds were evaluated for their cytotoxicity and their ability to inhibit EGFR phosphorylation. Subsequently, the combined action of the compounds with radiation was studied as well as, their possible involvement in the mechanisms underlying radiosensitivity, such as cell cycle arrest, cell death induction, G2/M checkpoint abrogation and repair mechanisms. Three promising compounds with anti-cancer and radiosensitising activity emerged from this thesis. The compound N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-ε-isocyanohexanamide (C3) is a quinazoline derivative, while fac-[Re(CO)3(imQz)(Br)] (B1) and fac-[Re(CO)3(imQz)(pph3)](PF6) (B2) are rhenium complexes bearing the 4-anilino-quinazoline as pharmacophore. The two complexes are multi-target compounds since, the results suggest, not only EGFR inhibition, but also interaction with DNA. The B2 complex also induces cell death possibly by targeting mitochondria. The induction of radiosensitivity by these compounds may be a combination of several mechanisms, including cell cycle arrest and their involvement in cell repair mechanisms acting in the G1 phase of the cell cycle.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Triantopoulou, Sotiria
  • Τριαντοπούλου, Σωτηρία

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/59412

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Triantopoulou, Sotiria; Τριαντοπούλου, Σωτηρία. Μελέτη επαγωγής ακτινοευαισθησίας νέων παραγώγων κιναζολινών με αντικαρκινική δράση σε καρκινικές κυτταρικές σειρές που υπερεκφράζουν υποδοχείς ErbB.. University of Crete (UOC), 2025. http://hdl.handle.net/10442/hedi/59412